Premium
Second and early third trimester pregnancy termination by extra‐amniotic balloon and intracervical PGE 2
Author(s) -
Liu H.S.,
Yu M.H.,
Chang Y.K.,
Chu T.Y.
Publication year - 1998
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(97)00240-3
Subject(s) - medicine , pregnancy , obstetrics , balloon , gestation , abortion , products of conception , second trimester , gynecology , surgery , genetics , biology
Objective: The aim of the study was to investigate the efficacy and safety of an alternative modality using extra‐amniotic balloon and intracervical prostaglandin (PG) E 2 for termination of second and early third trimester pregnancies. Method: Thirty‐three pregnant women scheduled for legal termination of pregnancy at 15–32 weeks' gestation were included in the study. Each case received extra‐amniotic balloon containing 500–800 ml normal saline and two PGE 2 tablets inserted into the cervical canal. Results: All 33 patients achieved a successful termination. The mean induction‐to‐abortion interval was 12.85 h. There was no significant difference in induction‐to‐abortion interval between second trimester group and third trimester group. However, the mean duration of balloon distention was longer in the second trimester group. There were no severe complications. Conclusion: The combined use of extra‐amniotic balloon and intracervical PGE 2 tablets is effective, safe and convenient for termination of second and early third trimester pregnancy.